4.4 Review

Roles for VEGF in the adult

期刊

MICROVASCULAR RESEARCH
卷 74, 期 2-3, 页码 100-113

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mvr.2007.03.004

关键词

VEGF; angiogenesis; preeclampsia; anti-angiogenic therapy; bevacizumab; endothelial cells; avastin; fenestrations

资金

  1. NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER
  2. NATIONAL EYE INSTITUTE [R01EY015435, R01EY005318] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM065079] Funding Source: NIH RePORTER
  4. NCI NIH HHS [P01 CA045548, CA45548] Funding Source: Medline
  5. NEI NIH HHS [EY15435, R01 EY015435, R01 EY005318, R01 EY005318-23, R01 EY015435-04, EY05318] Funding Source: Medline
  6. NIGMS NIH HHS [F31 GM065079, F31 GM065079-05, NIH-F31-GM65079] Funding Source: Medline

向作者/读者索取更多资源

The role of VEGF during development and in pathology is well known, but its function in normal adult tissues is poorly understood. Adverse effects associated with the use of anti-angiogenic therapies targeting VEGF in human pathologies have begun to reveal potential functions of VEGF in quiescent vasculature. Further clues from expression studies of VEGF and its receptors in the adult, from the disease precclampsia, and from experimental neutralization studies, have suggested that VEGF is involved in endothelial cell survival and fenestration, as well as in the signaling and maintenance of non-endothelial cells. The various biochemical properties of VEGF, and its interaction with other growth factors, may be an important point in determining whether VEGF functions as a maintenance factor versus an angiogenic factor. A thorough understanding of the function of VEGF in the adult may lead to more efficacious pro- and anti-angiogenic therapies. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据